z-logo
open-access-imgOpen Access
Frailty and ageing
Author(s) -
Ken Woodhouse,
M. S. O'Mahony
Publication year - 1997
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/26.4.245
Subject(s) - medicine , ageing , gerontology
Most elderly people are not at all sans everything and lead full and active lives at home. However, as any organism ages it becomes less and less able to adapt to challenges from the internal and external environment. Initially this may manifest itself only under circumstances of extreme stress and be reflected in an increased likelihood of death following major events such as severe trauma, overwhelming sepsis or heroic surgery. As adaptability fails even more with progressive ageing, minor events—such as less severe injury, relatively trivial infections or injudicious use of drugs—may precipitate catastrophic functional failure. Over the years, gerontological researchers have attempted to separate the effects of 'true' ageing from the effects of age-related disease, although the practical usefulness of these efforts has been questioned by several authorities [1]. In addition, geriatricians have recogni2ed a clinical presentation characterized by 'a multisystem reduction in physiological capacity' and not necessarily related to a specific single disease process. A variety of terms have arisen to describe this or similar syndromes [2, 3], but 'frailty' is perhaps the most commonly used. Two problems arise with the concept of frailty: the first is one of definition—whilst most doctors use the term 'frail', there is considerable variation in what they mean by it. In particular, a geriatrician's concept of 'frail' may be very different to that of a gastroenterologist or an orthopaedic surgeon. The second problem is one of quantification—exactly how frail is 'frail'?: clearly it is not an all-or-none phenomenon and different patients will exhibit different degrees of frailty. These issues are well demonstrated in the field of geriatric pharmacology. Many early studies of drug metabolism in elderly people used geriatric patients and demonstrated a dramatic reduction in drug clearance compared to young volunteers (see [4] for review). It was soon realised that these changes were due more to concurrent disease and 'frailty' than to age per se [5]. As a result, more recent studies have used well-screened 'fit' older people — the problem here being that the screening is sometimes so stringent that we are investigating the 'super-old', who really do not represent the general elderly population at all. hi an attempt to overcome at least some of these problems, a group of geriatricians and pharmacologists proposed a working definition of 'frail' and 'fit' almost 10 years ago [6]. This definition was based almost entirely on function and the ability (or not) to perform activities of daily living (ADL). It did not pretend to quantify frailty, merely defining the ends of a spectrum; similarly it did not purport to identify the multiplicity of physiological deficits underlying the condition. Nonetheless, this simple and pragmatic definition has provided a useful tool to investigate the factors which are important in determining drug handling in elderly subjects. The problems mentioned above are compounded by the fact that 'frailty' may not be static—again, using drug metabolism as an example, events that increase 'frailty' may have a profound effect on some drug metabolizing enzymes, with a return towards normality on recovery [7]. Over the past decade, various groups have advanced the concept of frailty, hi particular, attempts have been made to more clearly conceptualize and define the problem [8-10], to quantify the level of defined,frailty and to use such quantified measures to predict either risk of disability or medico-social outcome [10-12]. The paper by Campbell and Buchner in this issue of Age and Ageing [13] usefully extends the debate on 'frailty'. They define frailty in a systematic way and emphasize the difference between the frail patient and someone who is simply disabled. They argue that the condition of frailty can be diagnosed clinically by measuring certain parameters which are essential for successful interaction with the environment. Their measures include several measures of physical performance, an exercise test, Mini-Mental State Examination (MMSE) and anthropometric measurements. However, a scoring system based on this combination of specific measurements has yet to be evaluated in a widespread manner.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom